Oracle has announced a new unified cloud-based eClinical platform with the intentions of speeding up the process of bringing new drugs to market. The solution, dubbed “Clinical One” unifies clinical development operations under one centralized cloud-based platform.
Bringing drugs to market is a complicated, expensive process. It involves the initial development of the drug, extensive testing, and regulatory checks that all occur before the drug can even be sold. A report from MedicineNet indicates that such a process takes an average of 12 years in the United States, with costs exceeding tens of millions of dollars.
By bringing the process to the cloud, Oracle hopes to shorten the time-to-market for new drugs and many of the costs associated with redundancies and siloed clinical solutions that currently make up the clinical trial process.
Oracle said, “Today, clinical operations rely on a collection of point solutions that sit in silos and work independently of each other, creating redundancy and inefficiency. The only way to make a true impact on trial efficiency is to reimagine how technology supports the entire drug development lifecycle.”
The Oracle Health Sciences Clinical One cloud environment is an effort to provide universal access to information and common tools that every organization interacts with, the process becomes more unified and less redundant. Oracle hopes that by creating this platform, the time-to-market for new drugs will be greatly reduced.
An All-in-one Solution
Oracle claims the Clinical One platform is an “all-in-one solution” for new drug clinical processes. It’s a cloud-based solution, which Oracle believes would consolidate the various separate systems being used today and unifying them under a single umbrella.
Being based in the cloud, the same data would be accessible from anywhere in the world, and to any organizations involved in a drug’s clinical trials.
“The Oracle Health Sciences Clinical One platform is the only cloud environment built from the ground to support the core capabilities required for effective study management throughout the entire clinical development lifecycle — from design and planning to start-up and conduct, to close-out and post-marketing,” Jim Streeter, Global Vice President Life Sciences Product Strategy, Oracle, said in a statement.
Randomization and Supplies Management
The first component of the new platform is the Clinical One Randomization and Supplies Management. It’s a system that assists in the configuration of randomization strategies by study size, site, or region. A Depot Management function limits the type of data handlers of drug kits and inventory see and manage.
The first region being targeted for the new platform is India, where the clinical trials market has been experiencing rapid growth in recent years.
Oracle has created what it hopes will be a universally-utilized platform that handles virtually all aspects of the clinical steps to bring new drugs to market. Will it work? A recent article by Information Age indicates that the clinical market is primed for cloud integration and that such a solution may well bring more drugs to market faster, without risk to quality or safety.